Cargando…
Overexpression of PP2A inhibitor SET oncoprotein is associated with tumor progression and poor prognosis in human non-small cell lung cancer
SET oncoprotein is an endogenous inhibitor of protein phosphatase 2A (PP2A), and SET-mediated PP2A inhibition is an important regulatory mechanism for promoting cancer initiation and progression of several types of human leukemia disease. However, its potential relevance in solid tumors as non-small...
Autores principales: | Liu, Hao, Gu, Yixue, Wang, Hongsheng, Yin, Jiang, Zheng, Guopei, Zhang, Zhijie, Lu, Minyin, Wang, Chenkun, He, Zhimin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558125/ https://www.ncbi.nlm.nih.gov/pubmed/25945834 |
Ejemplares similares
-
MicroRNA-493 Suppresses Tumor Growth, Invasion and Metastasis of Lung Cancer by Regulating E2F1
por: Gu, Yixue, et al.
Publicado: (2014) -
Retraction: MicroRNA-493 Suppresses Tumor Growth, Invasion and Metastasis of Lung cancer by Regulating E2F1
por: Gu, Yixue, et al.
Publicado: (2019) -
Apoptosis inhibitor-5 overexpression is associated with tumor progression and poor prognosis in patients with cervical cancer
por: Cho, Hanbyoul, et al.
Publicado: (2014) -
Nuclear overexpression of bcl-2 oncoprotein during the progression of human stomach cancer.
por: Lee, S. S., et al.
Publicado: (1998) -
Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma
por: Li, Mei-Xiang, et al.
Publicado: (2021)